  Proteomics will celebrate its 20th year in 2014. In this relatively short
period of time, it has invaded most areas of biology and its use will probably
continue to spread in the future. These two decades have seen a considerable
increase in the speed and sensitivity of protein identification and
characterization, even from complex samples. Indeed, what was a challenge
twenty years ago is now little more than a daily routine. Although not
completely over, the technological challenge now makes room to another
challenge, which is the best possible appraisal and exploitation of proteomic
data to draw the best possible conclusions from a biological point of view. The
point developed in this paper is that proteomic data are almost always
fragmentary. This means in turn that although better than an mRNA level, a
protein level is often insufficient to draw a valid conclusion from a
biological point of view, especially in a world where PTMs play such an
important role. This means in turn that transformation of proteomic data into
biological data requires an important intermediate layer of functional
validation, i.e. not merely the confirmation of protein abundance changes by
other methods, but a functional appraisal of the biological consequences of the
protein level changes highlighted by the proteomic screens.
